CW Curtiss-Wright

Curtiss-Wright provides aerospace and defense products, industrial automation systems, and commercial nuclear solutions to government and private sector customers. Sector: Industrials.

Curtiss-Wright (CW) is an individual stock. The analysis below presents key financial metrics for the company, covering profitability, capital efficiency, valuation, margins, and growth.

On the question of capital productivity, ROIC is 13.45%, WACC is 9.13%, and the economic spread is 4.31%. On balance, returns on capital just exceed funding costs, implying limited but real value creation at the margin. Supporting metrics show ROE at 19.18% and ROA at 8.87%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a company that is value-creative but with less room for execution slippage.

From a market pricing perspective, trailing P/E of 53.99, forward P/E of 46.26, PEG of 3.42. A modest gap between trailing and forward multiples implies the market is pricing incremental earnings improvement rather than a step-change in profitability. On a growth-adjusted basis, the company carries a premium valuation relative to its growth rate. The company carries an aggregate current ratio of 1.44, pointing to constrained near-term balance sheet coverage. The overall valuation picture is one where the market is paying for a specific earnings and growth outcome — and where any deviation from that path would likely pressure multiples.

The margin stack reads as follows: gross margin sits at 37.20%, operating margin at 18.72%, and free cash flow margin at 15.83%. Gross margins are in the moderate range, typical of sectors where direct costs consume a larger share of revenue. The company's operating margins are solid, pointing to overhead management that appears to be a relative strength. FCF margins are constructive here, reflecting the company that generate cash reliably after reinvestment requirements. The profile is not weak, but it is uneven enough that execution and cost control remain central to the forward case.

Where growth and expectations intersect, the estimated 12-month price change of -4.81%, where analyst assumptions imply downside unless operating trends re-accelerate, while TTM revenue growth of 14.88% suggesting the company is growing revenues at a measured, sustainable pace. The projected 12-month EPS growth rate of 16.7% is a standout component of the forward case — meaningful earnings expansion at this scale typically warrants attention from growth-oriented investors. Both signals are useful lenses, but they tend to diverge most sharply near inflection points in both business fundamentals and market sentiment. The durability of both the operating trend and analyst optimism will determine whether the current setup translates into measurable near-term returns. The estimated 12-month price change is based on analyst consensus price target estimates, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

There is enough quality in the profile to avoid outright concern, but not enough uniform strength to take high conviction in a direction. Patience has merit here.

This assessment is based solely on the quantitative metrics presented above and does not constitute financial advice. Investors should consider their own risk tolerance and conduct independent research before making investment decisions.